Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$85.28 - $112.6 $1 Million - $1.33 Million
11,784 Added 481.96%
14,229 $1.54 Million
Q1 2024

May 14, 2024

SELL
$59.21 - $92.9 $581,264 - $911,999
-9,817 Reduced 80.06%
2,445 $224,000
Q4 2023

Feb 09, 2024

BUY
$37.55 - $62.64 $87,566 - $146,076
2,332 Added 23.48%
12,262 $768,000
Q3 2023

Nov 14, 2023

BUY
$43.4 - $62.52 $430,962 - $620,823
9,930 New
9,930 $439,000
Q3 2022

Nov 14, 2022

BUY
$36.93 - $56.68 $476,397 - $731,172
12,900 New
12,900 $565,000
Q3 2022

Nov 14, 2022

BUY
$36.93 - $56.68 $476,397 - $731,172
12,900 New
12,900 $565,000
Q3 2021

Nov 15, 2021

SELL
$100.17 - $126.36 $2.52 Million - $3.17 Million
-25,120 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$86.05 - $119.72 $2.16 Million - $3.01 Million
25,120 New
25,120 $2.85 Million
Q1 2021

May 14, 2021

SELL
$91.47 - $124.36 $303,497 - $412,626
-3,318 Closed
0 $0
Q4 2020

Feb 11, 2021

SELL
$66.66 - $111.74 $725,860 - $1.22 Million
-10,889 Reduced 76.65%
3,318 $330,000
Q3 2020

Nov 13, 2020

SELL
$45.89 - $72.67 $88,613 - $140,325
-1,931 Reduced 11.97%
14,207 $1.03 Million
Q2 2020

Aug 14, 2020

SELL
$26.36 - $49.86 $477,669 - $903,513
-18,121 Reduced 52.89%
16,138 $805,000
Q1 2020

May 13, 2020

BUY
$17.27 - $40.17 $337,766 - $785,644
19,558 Added 133.04%
34,259 $1.02 Million
Q4 2019

Feb 14, 2020

BUY
$32.1 - $40.4 $471,902 - $593,920
14,701 New
14,701 $495,000
Q3 2019

Nov 14, 2019

SELL
$25.38 - $34.89 $254,688 - $350,121
-10,035 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$17.75 - $27.58 $178,121 - $276,765
10,035 New
10,035 $277,000
Q4 2018

Feb 13, 2019

SELL
$12.32 - $24.38 $165,457 - $327,423
-13,430 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$18.82 - $28.96 $252,752 - $388,932
13,430 New
13,430 $322,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.3B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Dynamic Technology Lab Private LTD Portfolio

Follow Dynamic Technology Lab Private LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.